Treatment of Multiple Sclerosis and Related Disorders: What's New in the Past 2 Years?
- 1 January 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 26 (1) , 28-37
Abstract
No abstract availableThis publication has 70 references indexed in Scilit:
- Sponsorship, Authorship, and AccountabilityNew England Journal of Medicine, 2001
- Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: how valid is the GABAergic hypothesis?Journal of Neurology, Neurosurgery & Psychiatry, 2001
- Vaccinations and the Risk of Relapse in Multiple SclerosisNew England Journal of Medicine, 2001
- Botulinum toxin (Dysport(R)) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging studyJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Evaluation of three different ways of assessing tremor in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2000
- School-based hepatitis B vaccination programme and adolescent multiple sclerosisThe Lancet, 2000
- Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Amelioration of flulike symptoms at the onset of interferon β‐ 1b therapy in multiple sclerosis by low‐dose oral steroids is related to a decrease in interleukin‐6 inductionAnnals of Neurology, 1998
- TreatmentsMultiple Sclerosis Journal, 1998
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983